BC Week In Review | Nov 2, 2009
Company News

King, Merck KGaA sales and marketing update

Merck's Merck Sante S.A.S. subsidiary granted King exclusive rights to commercialize Cyanokit hydroxocobalamin in the U.S., where it is approved to treat known or suspected cyanide poisoning. King said Cyanokit is a good fit for...
BC Week In Review | Oct 9, 2006
Clinical News

Duodote regulatory update

FDA approved Duodote atropine and pralidoxime injection for use by trained medical services personnel to treat civilians exposed to life-threatening organophosphorus-containing nerve agents such as sarin and insecticides. In 2002, FDA approved the injection under...
Items per page:
1 - 2 of 2